Literature DB >> 6252105

Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole.

L C Cucé, E L Wroclawski, S A Sampaio.   

Abstract

The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis. The drug was administered orally in a dosage of 200 to 400 mg per day within a period of up to 90 days. The results of the treatment for paracoccidioidomycosis were of cicatrization of the cutaneous lesions in three to four weeks in 24 patients and in two, from six to seven weeks. Out of 27 patients, 14 presented pulmonary lesions. The evolution within a 90-day period showed radiological cure in one case, improvement in seven, and unaltered picture in five patients. In one, there was no further control. In the three out of four cases of candidiasis there was clinical and mycological cure and in one case marked improvement. In seven cases of chromomycosis there was marked improvement in two, moderate in four, and slight in one case. There was slight improvement in one case of lobomycosis, and in eight cases of mycetoma moderate improvement in three, slight in three and none in two, but the mycological examinations were still positive. The drug tolerance was excellent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252105     DOI: 10.1111/j.1365-4362.1980.tb03740.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  7 in total

Review 1.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 2.  Lobomycosis Epidemiology and Management: The Quest for a Cure for the Most Neglected of Neglected Tropical Diseases.

Authors:  Franciely G Gonçalves; Patrícia S Rosa; Andrea de F F Belone; Léia B Carneiro; Vania L Q de Barros; Rosineide F Bispo; Yally A da S Sbardelott; Sebastião A V M Neves; Amy Y Vittor; William J Woods; Gabriel Z Laporta
Journal:  J Fungi (Basel)       Date:  2022-05-10

3.  In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.

Authors:  C N Okeke; H C Gugnani
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

4.  Paracoccidioidomycosis: a comparative study of the evolutionary serologic, clinical and radiologic results for patients treated with ketoconazole or amphotericin B plus sulfonamides.

Authors:  S A Marques; N L Dillon; M F Franco; M C Habermann; J C Lastoria; H O Stolf; J Marcondes; W Grizzo; N C Silva; M R Cavariani
Journal:  Mycopathologia       Date:  1985-01       Impact factor: 2.574

5.  In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.

Authors:  Abdalla O A Ahmed; Wendy W J van de Sande; Wim van Vianen; Alex van Belkum; Ahmed H Fahal; Henri A Verbrugh; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 6.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

Review 7.  Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?

Authors:  Lívia do Carmo Silva; Amanda Alves de Oliveira; Dienny Rodrigues de Souza; Katheryne Lohany Barros Barbosa; Kleber Santiago Freitas E Silva; Marcos Antonio Batista Carvalho Júnior; Olívia Basso Rocha; Raisa Melo Lima; Thaynara Gonzaga Santos; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  J Fungi (Basel)       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.